Chlamydia Seminar
Chlamydia Seminar
Chlamydia Seminar
Dr.Ramesh.R
History
The
word Chlamydia is derived from Greek, which means over coat i.e inclusion bodies coating the host cell nucleus Trachoma was described in Egyptian papyri LGV was described in the 8th century The organism was first isolated from patients with LGV in 1930s Major breakthrough in 1960s was the development of tissue culture isolation procedures
Classification
Introduction
They
are nonmotile, obligatory intracellular bacteria with unique biphasic developmental cycle Tropism for squamous epithelial cells and macrophages Filterability and failure to grow in cell free media Absence of peptidoglycan in the cell 4 wall
Cont.
Chlamydiaceae
show less than 10% 16SrRNA gene diversity and <10% 23SrRNA gene diversity The genome size of the Chlamydiaceae ranges from 1.0 to 1.24 Mbp with a G+C content of about 40% LPS has low endotoxic activity compared to other bacteria due to unusual long chain fatty acids in lipid A
Cysteine
OmcB
Binds
Cont
Chlamydia
lack enzymes of the electron transport chain and so require ATP and nutrient resources from host cell Takes on two forms in its life cycle: Elementary body (EB) Reticulate body (RB)
non-replicating, infectious particle called the elementary body (EB, measuring 200-300nm)
Cont
The
genus Chlamydia contains four species 1.C trachomatis 2.C psittaci 3.C pneumoniae 4.C pecorum Species differentiation is based on growth characteristics, nucleic acid profile, antigens, plasmids and nature of the inclusion body
Cont
Species
C.psittaci Many C. Trachoma trachomatis D-K LGV C.pneumoniae TWAR
Biovars
Humans
Antigens
Genus
-specific antigens: heat-stable LPS as an immunodominant component. Antibody to these antigens can be detected by CF and immunofluorescence Species-specific or serovarspecific antigens Antigens are mainly outer membrane proteins(MOMP). Specific antigens can best be detected by immunofluorescence,particularl y using monoclonal antibodies.
12
Pathogenesis
An
elementary body attaches to a susceptible epithelial cells by using heparin sulfate as a bridge Enters the epithelial cell by receptor mediated endocytosis The EB undergoes reorganization into larger replicative form, the reticulate body The RBs are osmotically unstable and incapable of infecting another cell
Cont RBs synthesize their own DNA, RNA and protein but lack the necessary metabolic pathways to produce high-energy phosphate compounds. They divide by binary fission The organisms are released from the infected cells by cell lyses(C.psittaci) or exocytosis(C.trachomatis)
15
Developmental cycle
16
17
Chlamydia trachomatis
The
name trachoma comes from 'trakhus' meaning rough which characterizes the appearance of the conjunctiva. It is one of the commonest cause of preventable blindness and impose a significant burden on humans globally It has been estimated that worldwide 500 million people are affected by ocular trachoma with some 7-9 million blind as a result
Cont.
Contains
18 serovars Serovars A,B,Ba and C are associated with trachoma Serovars D through K including the serovars Da, Ia and Ja are associated with genital tract diseases(most common STD) Serovars L1, L2,L2a, L2b and L3 are associated with LGV(STD)
Risk Factors
Adolescence New
or multiple sex partners History of STD infection Presence of another STD Oral contraceptive user Lack of barrier contraception
20
Men
Conjunctivitis Urethritis Prostatitis Conjunctivitis Urethritis Cervicitis Proctitis Conjunctivitis Pneumonitis Pharyngitis Rhinitis
Women
Infants
21
C.
22
Cont
23
Inflammatory Disease (PID) Salpingitis Endometritis Perihepatitis (Fitz-Hugh-Curtis Syndrome) Reiters Syndrome
24
Inclusion Pneumonia
25
Chlamydia psittaci
The
term psittacosis is Greek word, meaning parrot It is common in birds and domestic animals The infection is generally spread by the respiratory route and direct contact The severity of the disease ranges from inapparent or mild disease to a fatal systemic illness with prominent respiratory symptoms
Chlamydia species It is the most common cause of human infections The TWAR is the only serovar of C.pneumoniae It is transmitted from person to person by respiratory tract secretions The clinical manifestations of an acute C.pneumoniae infection can range from asymptomatic to life threatening illness
Cont
A
special association of C.pneumoniae infections with asthma has been proposed studies have associated coronary artery disease and atherosclerosis with antibody to C.pneumoniae organism has been demonstrated in atheromatous plaques of coronary arteries
Seroepidemiologic
The
Laboratory diagnosis
Microscopic
demonstration of inclusion or elementary bodies Isolation of Chlamydia Demonstration of Chlamydial antigens Nucleic Acid Amplification Tests (NAATs) serology
As
they are obligate intracellular pathogens, specimen collection should include the host cells that harbor the organisms Specimens should be forwarded to the laboratory with in 24 h in a special Chlamydial transport medium such as 2 sucrose phosphate or sucrose phosphate glutamate supplemented with fetal calf serum(5-10%), gentamicin(10ug/ml), vancomycin(25100ug/ml) and amphotericin B(2ug/ml) or nystatin(25u/ml)
can be stored at -700C when there is a delay in processing more than 24 h for culture should not be stored at -200C or in frost free freezers
Specimens
Cont
Cervical
and ocular specimens are collected by scrapings with the help of Dacron tip or rayon swabs with an aluminum or plastic shaft tips made of calcium alginate with wooden shafts may inhibit the chlamydiae
Swab
Chlamydia trachomatis
First
void urine ( first 10-30ml) and vulvovaginal swab specimen are useful for NAATs may be stored at ambient temperature and should be processed with in 24h to avoid denaturation of chlamydial DNA
Samples
Cont. Traditional sites for specimen collection in genital tract infection involve the endocervixin females and the urethra in males Purulent discharges/mucus have to be cleaned with sterile saline before swab is inserted 1 to 2 cm in to the cervical os past the squamo-columnar junction and rotated more than two times and removed without touching the
the conjunctiva with anesthetic eye drops Clean the mucus/discharge with sterile saline Use thin blunt end of spatula to scrape whole conjunctiva Spread the specimen evenly on a slide Air dry the smear and fix it with methanol for Giemsa staining or acetone for flurochrome staining
Cont.
Urethral
specimens from males are collected by placing a dry swab 34cm into the urethra and rotating more than twice Urination prior to specimen collection may reduce test sensitivity by washing out infected columnar cells In salpingitis, LGV, samples may be collected by needle aspiration of the involved fallopian tube and buboes
Cont
Specimens
for C. pneumoniae include sputum, bronchoalveoalar lavage fluid, nasopharyngeal aspirates, throat washings and throat swabs Specimens for C. psittaci include sputum, BAL fluid, pleural fluid, blood and tissue biopsy Liquid specimens are collected in a transport medium at a specimen to medium ratio of 1:2
Cont. Tissues taken at autopsy or sputum should be homogenized or shaken with glass beads in sucrose potassium glutamate Specimens collected by swabs should be shaken for 1min on a vortex mixer It is centrifuged at 500g for 5 min to remove cellular debris and stored at -600C until tested
Presumptive diagnosis
A
presumptive diagnosis of acute chlamydial infection in male patients is made when 1. 5 pus cells/hpf in Gram stained urethral smear and no intracellular Gram negative diplococci or 2. More than 20 pus cells in a first voided urine specimen
Staining properties
EBs
stain purple with Giemsa stainin contrast to the blue of host cell cytoplasm. RBs stain blue with Giemsa stain. The Gram reaction of chlamydiae is negative or variable and is not useful in identification. Staining with iodine can distinguish between inclusion bodies of C trachomatis and C psittaci, as only the former contain glycogen Inclusions stain brightly by immunofluorescence ,with group44 specific,species-specific, or serovarspecific antibodies.
of choice for diagnosis of genital C.trachomatis infections in routine clinical laboratories NAATs may be used for screening programs PCR and strand displacement amplification(SDA) assay amplify nucleotide sequences of the cryptic plasmid Transcription mediated amplification based assays target specific sequences of the 23SrRNA
isothiocyanate conjugated monoclonal antibodies directed against C trachomatis specific epitope of the MOMP is used They are based on detecting EBs in smears The procedure offers rapid diagnosis(30 min) It has sensitivity of 75-85% and specificity of 98-99%
Enzyme immunoassay
Monoclonal
or polyclonal antibodies are used to detect chlamydial LPS It has sensitivity of 62-72% when culture is used as reference standard There is a risk of false positive results due to cross reaction with LPS of other microorganisms
Isolation
Historically the gold standard Sensitivity and specificity are
close to 100% Use in legal investigations Not suitable for widespread screening Disadvantages include technical complexity, long turnaround time, and stringent requirements related to collection, transport and storage of specimens
Isolation procedures
C.pneumoniae
and C.trachomatis are BSL-2 organisms, where as C.psittaci is a BSL-3 organism Transmission of the organisms from patient specimens or infected cell cultures may occur through aerosols, splashes in to mucous membranes and hand to face actions
Cont. Preventing laboratory acquired infections include the use of gloves, alcohol based hand disinfectants, safety centrifuge caps and face protection Laboratory infection with C.trachomatis usually manifest as follicular conjuctivitis The LGV strains are more invasive and causes severe pneumonia and lymphadenitis
Cont. McCoy and HeLa 229 cells are most commonly used for C.trachomatis HL and Hep-2 cells are used for the isolation of fastidious C.pneumoniae Host cells are plated either onto 12mm glass cover slips contained in 15mm diameter disposable glass vials or in tissue culture plates (6,12, 24 well)
Cont. The cells are seeded in a conc of 1x105 to 2x105 cells/ml Confluent monolayer formation occurs with in 24-48 h Specimens are thoroughly vortexed with glass beads in a tightly closed vials to facilitate the release of chlamydiae and inoculated onto the cell monolayers(with in 24 h of confluency)
Cont. The inoculated specimen is centrifuged on to the cell monolayer's at 900 to 3000 X g for 1 h at 22-350C Cells are incubated at 350C for 1-2 h to allow uptake of chlamydiae Then chlamydial isolation medium consisting of the cell culture medium supplemented with fetal calf serum(10%), L-glutamate(2mM), cycloheximide, gentamicin, vancomycin and amphoterecin B is added and incubated at 350C in 5%CO2 for 48-72h
It
involves demonstration of intracytoplasmic inclusions by fluorescent antibody staining Cultures can be screened by using fluorescein isothiocyanate conjugated anti-LPS antibody which recognizes all chlamydiae Other methods of staining include Giemsa and iodine staining
Identification
Cont Confirmation of positive genital cultures can be done by the use of a C.trachomatis MOMP specific monoclonal antibody Identification of replicating chlamydiae can also be done by fluorescence in situ hybridization using fluorescent labeled oligonucleotide probes complementary to order, genus and species specific target sites on the chlamydial 16S rRNA
0.2-0.5ml suspension of specimen treated with gentamicin(500ug/ml) and nystatin(100u/ml) in to the yolk sac of each six embryos Incubation at 350C Eggs candled daily and discard any embryo which die with in 48 hours
Cont. Harvest yolk sacs of the embryo after 13 days of inoculation Impression smears are prepared from the yolk sac and stained with Giemsa or Gimenez Observe for the elementary bodies The yolk sac method is used for preparing antigens for the microimmunofluorescence test
Serological tests
Complement Microimmunofluorescence Enzyme
immunoassay
is based on antibody reactivity to the Chlamydia LPS antigen It may be useful in diagnosing symptomatic LGV and psittacosis. A titer of >256 strongly supports the clinical diagnosis of LGV It is not recommended for the diagnosis of C.pneumoniae, trachoma, inclusion conjunctivitis due to cross reactivity and low sensitivity
Microimmunofluorescence test
It
is the method of choice for serodiagnosis of chlamydial infections Species and serovar specific antibodies can be detected It allows quantitative detection of IgM and IgG antibodies, helpful in distinguishing recent from past infections
Cont It is performed using purified formalinized EBs of representative serovars of C. trachomatis, C.psittaci and C.pneumoniae that are dotted in a specific pattern onto glass slides Serial dilutions of patient sera are placed over the fixed antigen dots and incubated The bound antibody is detected with fluorescein- conjugated anti-IgG or anti-IgM antibody Fluorescence is read by UV microscopy
Cont It is the test of choice for C.trachomatis pneumonitis in infants(IgM titer of >32) and LGV(IgG titer >128)
Paired
sera demonstrating at least a fourfold rise in titer and single serum samples with IgM >16 and/or IgG >512 is also useful in diagnosing acute C.pneumoniae
Immunochromatographic tests
They Antigens
are sensitive, specific and rapid tests are extracted from the endocervical, urethral swabs or urine and identified min results can be read after 10
Test
has little clinical utility as in vitro resistance does not correlate with the patients clinical outcome It requires growing the organisms in epithelial cells cultured in medium containing increasing conc of antibiotics Cells are stained with an FITC-labeled antichlamydial antibody and the lowest concof antibiotic that prevents the inclusion formation after 48 h of incubation is reported
CDC -
7 days
63
Alternative regimens Erythromycin base 500 mg orally 4 times a day for 7 days, OR
Erythromycin
ethylsuccinate 800 mg orally 4 times a day for 7 days, OR 300 mg orally twice a day for 7 days 500 mg orally once a day for 7 days
Ofloxacin
Levofloxacin
women Repeat testing, preferably by NAAT, 3 weeks after completion of recommended therapy Non-pregnant women Test of cure not recommended unless compliance is in question, symptoms persist, or re-infection is suspected Repeat testing recommended 3-4 months after treatment, especially adolescents due to high prevalence of repeated infection
Prevention
66
can reduce the incidence of PID by more than 50%. decreases the prevalence of infection in the population and reduces the transmission of disease.
67
Screening
active women age 25 years and under should be screened annually. Women >25 years old should be screened if risk factors are present. Presentation for induced abortion
68
Sex
partners should be evaluated, tested, and treated if they had sexual contact with the patient during the 60 days preceding the onset of symptoms or diagnosis of Chlamydia. recent sex partner should be evaluated and treated even if the time of the last sexual contact was >60 days before symptom onset or diagnosis. of therapy to sex partners by heterosexual male or female patients 69 might be an option.
Partner Management
Most
Delivery
Chlamydia psittaci
Treatment
of infected birds with tetracycline, chlortetracycline, or doxycycline for at least 45 consecutive days Prophylactic treatment of all imported birds Quarantine of all imported birds for 30 days Environmental sanitation Avoiding close contact with birds and domestic animals
THANK YOU
REFERENCES Ananthanarayan and Panikers text book of microbiology Topley and Wilsons microbiology and microbial infections Manual of clinical microbiology, 9th edn. Mackie and McCartney, Practical medical microbiology
Transmission
Transmission
is sexual or vertical Highly transmissible Incubation period 7-21 days Significant asymptomatic reservoir exists in the population Re-infection is common Perinatal transmission results in neonatal conjunctivitis in 30%-50% of exposed babies 73
Transmission
08/21/11 microbiology 8-year course
C. pneumoniae
Person-to-person
C.psittaci
Infectionacquiredbycontactwith infectedbirdoranimal(may appearhealthy). Persontopersoninfectionvery uncommon.
74
Virulence factors
08/21/11 microbiology 8-year course
C. pneumoniae
Intracellular
replication; prevention of phagolysosome fusion; ability to infect and destroy ciliated epithelial cells of respiratory tract,smooth muscle cells,endothelial cells,and macrophages; extracellular survival of infectious EBs.
75
Clinical syndromes
08/21/11 microbiology 8-year course
C. pneumoniae
Bronchitis Pneumonia Sinusitis Pharyngitis atherosclerosis
76
Diagnosis
08/21/11 microbiology 8-year course
Sera and tears from infected humans are used to detect anti-Chlamydia antibodies by the complement fixation or microimmunofluorescence tests. The latter is useful for identifying specific serotypes of C trachomatis. Fluorescent monoclonal antibodies are used to stain C trachomatis elementary bodies in urethral and cervical exudates.
77
Diagnosis
08/21/11 microbiology 8-year course
It is possible to diagnose C trachomatis in tissue biopsy specimens by in situ DNA hybridization with cloned C trachomatis DNA probes. DNA from C trachomatis isolates can be examined by restriction endonuclease analysis. The DNA cleavage pattern of C trachomatis isolates differs greatly from that of DNA from C psittaci isolates. DNAs of the agents of trachoma and lymphogranuloma venereum differ in their cleavage patterns, and this allows identification of the biovars
78
Diagnosis
08/21/11 microbiology 8-year course
Chlamydia pneumoniae DNA has 10 percent homology with C trachomatis or C psittaci; C pneumoniae isolates have 100 percent homology. Chlamydia pneumoniae isolates can be diagnosed by hybridization with a specific DNA probe that does not hybridize to other chlamydiae. Two additional serologic tests are in use: the microimmunofluorescence test with C pneumoniae-specific elementary body antigen, and the complement fixation test, which measures Chlamydia
79
Taxonomy
Chlamydia trachomatis is an important pathogen of humans and 1 of 4 species within the genus C. trChlamydia trachomatis is an important pathogen of humans and 1 of 4 species within the genus C. trachomatis (natural host: humans) C. pneumoniae (natural host: humans) C. psittaci (natural host: birds, lower mammals) C. pecorum (natural host: sheep, cattle, and swine) 4 biovars of C. trachomatis Murine biovar Swine biovar Lymphogranuloma venereum (LGV) biovar Trachoma biovar achomatis (natural host: humans) C. pneumoniae (natural host: humans) C. psittaci (natural host: birds, lower mammals) C. pecorum (natural host: sheep, cattle, and swine) 4 biovars of C. trachomatis Murine biovar Swine biovar Lymphogranuloma venereum (LGV) biovar Trachoma biovar
80
C pneumoniae grows better in HL or Hep - 2 cells . All types of chlamydiae proliferate in embryonated eggs , particularly in the yolk sac .
Cell wall inhibitors ( penicillins ) result in the production of morphologically defective forms but are not effective in clinical diseases . 81 Inhibitors of protein synthesis ( tetracyclines , erythromycins ) are effective in
Classification C trachomatis
Biovar
82
Who is at risk?
C. trachomatis
People
with multiple sexual partners. Homosexuals,who are more at risk for LGV. Newborns born of infected mothers. Reiters syndrome: young white men. Trachoma:children,particularly those in crowded living conditions where sanitation and hygiene are poor.
83
Molecular Aspects
It
Two
Non-replicating, infectious elementary bodies (analogous to a spore) Replicating, non-infectious reticulate body (replicate inside host cell, in a membrane-bound inclusion) When the bacterium gains entrance to the host cells elementary bodies germinate into reticulate bodies
http://www.healthofchildren.com/images/gech_0001_0004_0_img0276.jpg
Pathogenicity
Trachoma (conjunctivitis)
Most
common cause of blindness in the world Direct contact with infected eye discharge or flies that have trouched an infected person Causes the inflammation of the eye Eyelids turn inwards so the eye lashes rub against the cornea causing scar tissue to form Irreversible blindness
Characteristics
Rod-shaped or cocciod Obligate intracellular parasites Aerobic Gram negative but difficult to stain Cell Wall lipopolysaccharides form the outer membrane, not peptidoglycan. Forms elementary bodies Non-motile 37C, mesophile G+C Content - 41.3%
Pathogenesis
08/21/11 microbiology 8-year course
EBs attach to the microvilli of susceptive cells. Penetration into the host cell via endocytosis or pinocytosis and forming phagosomes Fusion of lysomes with the EB-containing phagosome are inhibited EBs reorganize into the metabolically active RBs
87
Transmission C. trachomatis
Sexually Infected
transmitted;most frequent bacterial pathogen in united states. patients , who may be asymptomatic. through break in skin or membranes. to new born at birth.
Inoculation Passage
Trachoma
Non-LGV serovars
Conjunctivitis Proctitis Reiters
Syndrome
LGV serovars
Lymphogranuloma
venereum
89
infections
90
Virulence factors
C. trachomatis
Intracellular replication, prevention of phagolysosomal fusion, survival of infectious EBs as a result of crosslinkage of membrane proteins.
91
Pathogenicity
Transmitted through direct contact between infected membranes Genital tract infection
Asymptomatic in most cases Symptoms Painful urination Lower abdominal pain Unusual Discharge
If left untreated, common cause of infertility Newborns can contract the disease from infected mothers
Diagnosis
08/21/11 microbiology 8-year course
Chlamydia
trachomatis can be identified microscopically in scrapings from the eyes or the urogenital tract. bodies in scraped tissue cells are identified by iodine staining of glycogen present in the cytoplasmic vacuoles in infected cells.
Inclusion
93
Cont
To isolate the agent, cell homogenates that contain the chlamydial elementary bodies are centrifuged onto the cultured cells (e.g., irradiated McCoy cells). After incubation, typical cytoplasmic inclusions are seen in the cells stained with Giemsa stain or iodine.
CDC-recommended regimens
Azithromycin 1 g orally in a single dose, OR Amoxicillin 500 mg orally 3 times a day for 7 days
Alternative regimens
Erythromycin base 500 mg orally 4 times a day for 7 days, OR Erythromycin base 250 mg orally 4 times a day for 14 days, OR Erythromycin ethylsuccinate 800 mg orally 4 times a day for 7 days, OR Erythromycin ethylsuccinate 400 mg orally 4 times a day 95 for 14 days, OR
96
Children who weigh 45 kg, but are <8 years of age: Azithromycin 1 g orally in a single dose
Children 8 years of age: Azithromycin 1 g orally in a single dose, OR Doxycycline 100 mg orally twice a day for 7 days
97
Alternative regimen Erythromycin base 500 mg orally 4 times a day for 21 days
98
Diagnosis
Non-Amplication Tests
Direct
Detects
immunoassay (EIA)
Detects
Nucleic
Detects
Serology
Rarely used for uncomplicated infections Comparative data between types of serologic test are lacking Criteria used in LGV diagnosis
Complement
fixation titers >1:64 can support diagnosis in the appropriate clinical context Serologic test interpretation for LGV is not standardized
100
Cont
Both the particles are suspended in 3-5% normal yolk sac or egg albumin glycerol The antigens are spotted with fine pen nibs on clean glass microscopic slides Normal yolk sac 5% is spotted as controls The slides are air dried and fixed in acetone 10ul of serum/secretions are placed over each group of antigens
Cont..
Fluorescein-isothiocyanate conjugated antispecies immunoglobulin is placed over each spot Slides are then air dried and covered with glycerol based mounting fluid and a cover slip Fluorescence is read by UV microscopy
Sample collection
Smear specimens should be obtained with a conjunctival spatula. NEVER USE A SWAB (soft-tipped applicator) TO OBTAIN A SMEAR FOR CYTOLOGY After applying topical . anesthetic, specimens are directly collected by firmly scraping the exposed conjunctiva. These specimens are transferred to glass microscope slides, air-dried, and allowed to remain at room temperature. Viral transport media are not suitable substitutes, since these usually contain penicillin.
Cont..
Collected samples are placed in 2.0 ml of chlamydial transport medium. We have had great success with Bartels ChlamTrans Chlamydial transport medium and recommend its use. DO NOT USE VIRAL TRANSPORT MEDIUM THAT MAY CONTAIN ANTIBIOTICS THAT INHIBITS CHLAMYDIA GROWTH IN CELL CULTURE. Chlamydia is very fastidious and will not survive unless refrigerated (short-term) or frozen (longterm) (-75 degrees C).
Cont..
Smear specimens should be obtained with a conjunctival spatula. NEVER USE A SWAB (soft-tipped applicator) TO OBTAIN A SMEAR FOR CYTOLOGY After applying topical . anesthetic, specimens are directly collected by firmly scraping the exposed conjunctiva. These specimens are transferred to glass microscope slides, air-dried, and allowed to remain at room temperature
Examples of specimens that are generally not acceptable for testing by nonculture methods are vaginal, rectal, nasopharyngeal, or female urethral specimens. In cases of suspected sexual assault or abuse, only culture tests should be used regardless of the specimen site A specimen would be determined to be inadequate if any one of the following conditions exist: no cellular components, no columnar or metaplastic cells, or the presence of only squamous epithelial cells or PMNs. Detergent-based transport media such as those conventionallyused for DNA probe or DNA amplification testswill lyse chlamydial elementary bodies and columnar cells and cannot be used for assessment of specimen adequacy
Currently, CDC recommends that culture be used for the detection of C. trachomatis in urethral specimens from women and asymptomatic men, nasopharyngeal specimens from infants, rectal specimens from all patients, and vaginal specimens from prepubertal girls. In cases of suspected sexual abuse or assault, only culture tests should be used to diagnose C. trachomatis infection
Cont. Repeat testing of all women 3-4 months after treatment for C. trachomatis infection, especially adolescents.
Repeat
testing of all women treated for C. trachomatis when they next present for care within 12 months.